PROM1 and glioma: The liposome displays durable ability to target glioma cells and brain microvascular endothelial cells (BCECs) and to deliver drugs (PTX/siRNA) to CD133+ glioma stem cells, which exhibits great potential for targeted imaging and therapy of brain glioma stem cells.